Elanco Animal Health Incorporated (ELAN)

NYSE: ELAN · IEX Real-Time Price · USD
16.49
-0.44 (-2.60%)
At close: May 23, 2024, 4:00 PM
17.20
+0.71 (4.31%)
Pre-market: May 24, 2024, 8:00 AM EDT
-2.60%
Market Cap 8.15B
Revenue (ttm) 4.37B
Net Income (ttm) -1.30B
Shares Out 494.18M
EPS (ttm) -2.65
PE Ratio n/a
Forward PE 17.16
Dividend n/a
Ex-Dividend Date n/a
Volume 2,336,328
Open 16.90
Previous Close 16.93
Day's Range 16.32 - 16.91
52-Week Range 7.88 - 17.43
Beta 1.34
Analysts Buy
Price Target 18.33 (+11.16%)
Earnings Date May 8, 2024

About ELAN

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticid... [Read more]

Sector Healthcare
IPO Date Sep 20, 2018
Employees 9,800
Stock Exchange NYSE
Ticker Symbol ELAN
Full Company Profile

Financial Performance

In 2023, ELAN's revenue was $4.42 billion, an increase of 0.14% compared to the previous year's $4.41 billion. Losses were -$1.23 billion, 1478.2% more than in 2022.

Financial Statements

Analyst Forecast

According to 6 analysts, the average rating for ELAN stock is "Buy." The 12-month stock price forecast is $18.33, which is an increase of 11.16% from the latest price.

Price Target
$18.33
(11.16% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Elanco to Participate in Stifel 2024 Jaws and Paws Conference

GREENFIELD, Ind. , May 21, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the Stifel 2024 Jaws and Paws Conference on Wednesday, May 29, 2024.

3 days ago - PRNewsWire

Elanco Animal Health (ELAN) CEO on Earnings

Elanco Animal Health (ELAN) CEO Jeffrey Simmons joins Oliver Renick to discuss ELAN's 1Q earnings. He talks about how ELAN's shares hit a 52-week high.

15 days ago - Schwab Network

Elanco Animal Health Reports First Quarter 2024 Results

First Quarter 2024 Financial Results Revenue of $1,205 million Reported Net income of $32 million, Adjusted Net income of $167 million Adjusted EBITDA of $294 million, or 24.4% of Revenue Reported EPS...

16 days ago - PRNewsWire

Elanco Confirms Date and Conference Call for First Quarter 2024 Financial Results Announcement

GREENFIELD, Ind. , April 17, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will announce its first quarter 2024 financial results on Wednesday, May 8, 2024.

5 weeks ago - PRNewsWire

Elanco Appoints Two Animal Health Industry Executives, Kathy Turner and Craig Wallace, to its Board of Directors

New Directors Join the Board's Renamed Finance, Strategy and Oversight Committee Reaches Cooperation Agreement with Ancora GREENFIELD, Ind. , April 1, 2024 /PRNewswire/ -- Elanco Animal Health Incorpo...

7 weeks ago - PRNewsWire

Activist investor Ancora secures two Elanco board seats, Bloomberg News reports

Investment firm Ancora Holdings has reached an agreement with Elanco Animal Health to add two of its director candidates to the company's board, Bloomberg News reported late on Sunday, citing people w...

7 weeks ago - Reuters

Elanco Animal Health (ELAN) CEO on Pet Disease Prevention & Health Products

Elanco Animal Health (ELAN) offers pet disease prevention and nutritional health products. CEO Jeffrey Simmons joins Oliver Renick to give an overview of the company.

2 months ago - Schwab Network

Elanco Appoints Shiv O'Neill as General Counsel and Corporate Secretary

GREENFIELD, Ind. , March 4, 2024 /PRNewswire/ -- Elanco Animal Health (NYSE: ELAN) announced today the appointment of Shiv O'Neill as the company's Executive Vice President, General Counsel and Corpor...

2 months ago - PRNewsWire

Elanco Animal Health is Executing on Plan to Deliver for Shareholders

Ancora Nominates Director Candidates Despite Elanco's Meaningful Operational Progress and Good Faith Engagement with the Investor GREENFIELD, Ind. , Feb. 29, 2024 /PRNewswire/ -- Elanco Animal Health ...

3 months ago - PRNewsWire

Ancora Nominates Four Highly Qualified, Independent Director Candidates and Urges Orderly CEO Succession at Elanco Animal Health

CLEVELAND--(BUSINESS WIRE)--Ancora Holdings Group, LLC (together with its affiliates, “Ancora” or “we”), which owns approximately 3% of the outstanding common stock of Elanco Animal Health Incorporate...

3 months ago - Business Wire

Elanco Animal Health Reports Fourth Quarter and Full Year 2023 Results

Fourth Quarter 2023 Financial Results: Revenue of $1,035 million Reported Net Loss of $141 million, Adjusted Net Income of $39 million Adjusted EBITDA of $165 million or 15.9% of Revenue Reported EPS ...

3 months ago - PRNewsWire

Elanco to Participate in Upcoming Investor Conferences

GREENFIELD, Ind. , Feb. 22, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced that the Company will participate in the following investor conferences.

3 months ago - PRNewsWire

Beef 'agtech' company Cattler launches interface with Elanco for its Benchmark program

SARATOGA, Calif. , Feb. 8, 2024 /PRNewswire/ -- Cattler ( www.cattler.farm) announces the launch of its interface with Elanco Animal Health Incorporated (NYSE: ELAN), as part of the agreement reached...

3 months ago - PRNewsWire

Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2023 Financial Results Announcement

GREENFIELD, Ind. , Feb. 8, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will announce its fourth quarter and full year 2023 financial results on Monday, February 26, 2024.

3 months ago - PRNewsWire

Merck to Buy Elanco's Aqua Business for $1.3 Billion

Merck struck a deal to buy Elanco Animal Health's aqua business in a deal that expands the drugmaker's animal-health business.

Other symbols: MRK
3 months ago - WSJ

Merck to buy Elanco Animal Health's aqua business for $1.3 bln

Merck said on Monday it had agreed to buy Elanco Animal Health's aqua business for $1.3 billion in cash, to strengthen its portfolio of aquatic healthcare products.

Other symbols: MRK
3 months ago - Reuters

Elanco Animal Health agrees to sell aqua business to Merck for $1.3 billion in cash

Elanco Animal Health Inc. ELAN, -0.41% said Monday it has agreed to sell its aqua business to Merck Animal Health MRK, +0.02% for $1.3 billion in cash. Greenfield, Ind.

Other symbols: MRK
3 months ago - Market Watch

Merck Animal Health to Acquire Elanco's Aqua Business

RAHWAY, N.J.--(BUSINESS WIRE)--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced t...

Other symbols: MRK
3 months ago - Business Wire

Elanco Announces Sale of Aqua Business for $1.3 Billion

Transaction reinforces Elanco's commitment to most significant value creation opportunities in pet health and livestock sustainability Enables company to accelerate debt paydown by $1.05B to $1.1B GRE...

Other symbols: MRK
3 months ago - PRNewsWire

Tonisity and Elanco Announce Receipt of Permission from the Japanese Government for Tonisity Px Import and Sales

Tonisity and Elanco to Expand Partnership into the Japanese Swine Market Greenfield, Indiana, Fort Collins, Colorado, Basel, Switzerland and Dublin, Ireland--(Newsfile Corp. - January 31, 2024) - Elan...

4 months ago - Newsfile Corp

Elanco Animal Health CEO Jeff Simmons goes one-on-one with Jim Cramer

Elanco Animal Health President and CEO Jeff Simmons joins 'Mad Money' host Jim Cramer to talk its targeted treatment for parvovirus, the pet medicine market, working with Bayer and more.

4 months ago - CNBC Television

Elanco Launches Multi-Year Mission to Save 1 Million Puppies from Canine Parvovirus

Calling all Veterinarians and Pet Lovers - Take the "Defend Puppies. Defeat Parvo.

4 months ago - PRNewsWire

Stifel: ‘party is just getting started' in this stock up 80%

Elanco Animal Health Inc (NYSE: ELAN) has already gained a whopping 80% over the past two months but a Stifel analyst is convinced that the “party is just getting started”.

4 months ago - Invezz

Elanco Animal Health Announces Planned Board Leadership Changes and Corporate Governance Actions

Lawrence Kurzius to become next Chairman of the Board GREENFIELD, Ind. , Jan. 2, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) announced today that the Board of Directors has nam...

5 months ago - PRNewsWire

Ancora picks up a stake in Elanco. How the investor may push to help improve margins

A refreshment of the board may be on the horizon at the animal health company.

5 months ago - CNBC